| THE USE OF ANTIMALARIAL DRUGS |
LIST OF PARTICIPANTS
Technical advisers 1
- Dr Edugie Abebe, Director of Public Health, Federal Ministry of Health,
Garki, Abuja, Nigeria
- Dr Kevin Baird, Director, Parasitic Diseases Program, U.S. Naval Medical
Research Unit #2, American Embassy, Jakarta, Indonesia
- Dr Fred Binka, School of Public Health, University of Ghana, Accra, Ghana
- Professor Anders Björkman, Department of Infectious Diseases, Karolinska
Hospital, Stockholm, Sweden
- Dr Dennis Carroll, Senior Public Health Adviser, Office of health and
Nutrition, U.S. Agency for International Development, Washington DC, USA
- Professor Ogobara Doumbo, Department of Epidemiology of Parasitic Diseases,
Faculty of Medicine, University of Mali, Bamako, Mali
- Professor Oumar Gaye, Parasitology Service, Faculty of Medicine, C.A. Diop
University, Dakar, Senegal
- Ms Catherine Goodman, Research Fellow, Department of Medical Parasitology,
London School of Hygiene and Tropical Medicine, London, England
- Dr Tran Tinh Hien, Vice-Director, Centre for Tropical Diseases, Ho Chi Minh
City, Viet Nam
- Dr Peter Kazembe, Paediatrician, Lilongwe Central Hospital, Lilongwe, Malawi
- Dr Daniel B. Kebede, Head, Malaria and Other Vector-borne Diseases Control
Team, Ministry of Health, Addis Ababa, Ethiopia
- Dr Fred Kironde, Senior Lecturer, Crid Group, Department of Biochemistry,
Makerere University, Kampala, Uganda
- Dr Andrew Kitua, Director-General, National Institute for Medical Research,
Dar-es-Salaam, United Republic of Tanzania
- Dr Gilbert Kokwaro, Research Scientist, Wellcome Trust Research
Laboratories, Nairobi, Kenya
- Dr Anatoli Kondrachine, Geneva, Switzerland
- Professor Peter Kremsner, Institute of Tropical Medicine, University of
Tübingen, Tübingen, Germany
- Professor Sornchai Looareesuwan, Faculty of Tropical Medicine, Mahidol
University, Bangkok, Thailand
- Dr Kevin Marsh, Scientific Team Leader, Kemri-Wellcome Programme, Kemri
Wellcome Trust, Kilifi, Kenya
- Professor Maung Maung Wint, Director-General, Department of Medical
Sciences, Yangon, Myanmar
- Dr Hassan Mshinda, Director, Ifakara Health Research Centre, Ifakara, United
Republic of Tanzania
- Dr Anne McCarthy, Director, Tropical Medicine and International Health
Clinic, Ottawa Hospital General Campus, and Directorate Medical Policy, Department of National Defence, Ottawa, Canada
- Dr Sylvia Meek, Head, Malaria Consortium, London School of Hygiene and
Tropical Medicine, London, England
- Professor Malcolm Molyneux, Director, Malawi-Liverpool-Wellcome Clinical
Research Programme, College of Medicine, University of Malawi. Blantyre, Malawi
- Dr Maria Veronicah Mugisha-Makyanzi, Director of Epidemiology and Public
Hygiene, Ministry of Health, Kigali, Rwanda
- Dr Daniel Neyra, Director-Manager, National Malaria Control Programme,
Ministry of Health, Lima, Peru
- Dr Peter Olumese, Consultant Paediatrician/Clinical Pharmacologist,
Department of Pharmacology, University College Hospital, Ibadan, Nigeria
- Professor Pakdee Pothisiri. Director-General, Department of Medical
Sciences, Ministry of Public Health, Nondburi, Thailand
- Dr Trenton Ruebush (Rapporteur), Medical Officer, Centers for Disease
Control and Prevention, Atlanta, GA, USA
- Dr Alistair Robb, Senior Public Health Specialist, Health and Population
Department, Department for International Development, London, England
- Professor Lateef Salako (Chairman), Chief Executive, Federal Vaccine
Production Laboratory, Yaba, Lagos, Nigeria
- Dr Patricia Schlagenhauf, Research Scientist ISPM, University of Zurich,
Zurich, Switzerland
- Dr Chroeng Sokhan, Vice-Director, Department of Drugs and Food, Ministry of
Health, Phnom Penh, Cambodia
- Dr Akintunde Sowunmi, Department of Pharmacology and Therapeutics, College
of Medicine, University of Ibadan, Ibadan Oyo State, Nigeria
- Dr Richard Steketee, Division of Parasitic Diseases, Centers for Disease
Control and Prevention, Atlanta, GA, USA
- Dr Krongthong Thimasarn, Medical Officer/Senior Expert in Preventive
Medicine, Malaria Division, Department of Communicable Disease Control, Nonthaburi, Thailand
- Dr William Watkins, Mudford, Somerset, England
- Dr Neena Valecha, Assistant Director, Malaria Research Centre, Indian
Council of Medical Research, Delhi, India
- Professor Walther H. Wernsdorfer, Department of Specific Prophylaxis and
Tropical Medicine, University of Vienna, Vienna, Austria
- Dr Nicholas J. White, Faculty of Tropical Diseases, Mahidol University,
Bangkok, Thailand
- Dr Peter Winstanley, Reader in Clinical Pharmacology, Department of
Pharmacology and Therapeutics, University of Liverpool, Liverpool, England
- Dr Kojo Yeboah-Antwi, Director, Kintampo Health Research Centre, Kintampo,
Ghana
WHO Secretariat
Regional advisers
- Dr Poerwokoesoemo Roos Arbani, Regional Adviser - Malaria, WHO Regional
Office for South-East Asia, New Delhi, India
- Dr Hoda Atta, Medical Officer - Roll Back Malaria, WHO Regional Office for
the Eastern Mediterranean, Cairo, Egypt
- Dr Renato Gusmão, Program Coordinator, WHO Regional Office for the Americas,
Pan American Sanitary Bureau, Washington, DC, USA
- Dr Yao Kassankogno, Regional Adviser - Malaria, WHO Regional Office for
Africa, Parirenyatwa Hospital, Harare, Zimbabwe
- Dr Guido Sabatinelli, Regional Adviser - Malaria, WHO Regional Office for
Europe, Copenhagen, Denmark
- Dr Allan Schapira, Regional Adviser - Malaria, World Health Organization
Regional Office for Western Pacific, Manila, Philippines
- Dr Tom Sukwa, WHO Regional Office for Africa, Parirenyatwa Hospital, Harare,
Zimbabwe
WHO headquarters, Geneva, Switzerland
- Mr Richard J. Allan, Roll Back Malaria
- Dr Andrea Bosman, Roll Back Malaria
- Dr Charles Delacollette, Roll Back Malaria
- Dr David Evans, Evidence for Health Policy/Choosing Interventions:
Effectiveness, Quality, Costs, Gender and Ethics
- Dr Pascale Gilbert-Miguet, Joint medical Service
- Dr Melba Gomes, UNDP/World Bank/WHO Special Programme for Research and
Training in Tropical Diseases/Intervention Development and Evaluation
- Dr Robin Gray, Essential Drugs and Medicines Policy/Drug Action Programme
- Dr David L. Heymann, Executive Director, Communicable Diseases
- Dr Hans Hogerzeil, Essential Drugs and Medicines Policy/Drug Action
Programme
- Dr Tom Kanyok, Communicable Disease/Product Research and Development
- Dr Jane Kengeya Kayondo, UNDP/World Bank/WHO Special Programme for Research
and Training in Tropical Diseases/Intervention Development and Evaluation
- Dr Kamini N. Mendis, Roll Back Malaria
- Dr Carlos M. Morel, UNDP/World Bank/WHO Special Programme for Research and
Training in Tropical Diseases
- Dr David N. Nabarro, Director-General’s Office
- Dr Bernard L. Nahlen, Roll Back Malaria
- Dr Ayo Oduola, UNDP/World Bank/WHO Special Programme for Research and
Training in Tropical Diseases/Basic and Strategic Research
- Dr Piero L. Olliaro, UNDP/World Bank/WHO Special Programme for Research and
Training in Tropical Diseases/Intervention Development and Evaluation
- Dr Clive Ondari, Essential Drugs and Medicines Policy/Drug Action Programme
- Dr Robert G. Ridley, UNDP/World Bank/WHO Special Programme for Research and
Training in Tropical Diseases/Product Research and Development (Secretary)
- Dr Aafje E.C. Rietveld, Roll Back Malaria
- Dr J. Rigal, UNDP/World Bank/WHO Special Programme for Research and Training
in Tropical Diseases
- Dr Pascal Ringwald, Communicable Disease Surveillance and
Response/Anti-infective Drug Resistance Surveillance and Containment
- Ms Rima Shretta, Roll Back Malaria (Secretary)
- Dr Awash Teklehaimanot, Roll Back Malaria
- Dr Rosamund J. Williams, Communicable Disease Surveillance and
Response/Anti-infective Drug Resistance Surveillance and Containment
- Dr Fabio Zicker, UNDP/World Bank/WHO Special Programme for Research and
Training in Tropical Diseases /Research Capability Strengthening